V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001500 | 230011295 | 1.55 | 108.5 | null | 2022-03-29 | 2022-03-30 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100491722 |
| 230001520 | 230011298 | null | null | Palliative (P) | null | 2021-12-19 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100488711 |
| 230001528 | 230011299 | null | null | Palliative (P) | 2020-03-24 | 2020-04-17 | Niraparib | 02 | null | NIRAPARIB | 100311026 |
| 230001540 | 230011300 | null | null | null | null | 2020-04-07 | Olaparib | 02 | null | OLAPARIB | 100852176 |
| 230001549 | 230011301 | 1.57 | 54.7 | null | 2021-02-01 | 2021-08-21 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100038890 |
| 230001565 | 230011303 | null | null | Adjuvant (A) | null | 2019-10-14 | null | null | null | LIPOSOMAL DOXORUBICIN | 101673037 |
| 230001568 | 230011305 | null | null | Palliative (P) | null | 2020-08-25 | GEMCARBO | 02 | N | CARBOPLATIN + GEMCITABINE | 100179612 |
| 230001583 | 230011306 | 1.56 | 77.65 | null | 2020-10-03 | 2020-10-16 | Olaparib | 02 | null | OLAPARIB | 100144511 |
| 230001589 | 230011307 | 1.55 | 98.8 | null | 2018-10-08 | 2018-12-15 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100729650 |
| 230001620 | 230011309 | 1.62 | 66 | null | 2022-03-12 | 2022-04-03 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100388675 |
| 230001653 | 230011310 | 1.7 | 59.7 | Palliative (P) | 2019-04-16 | 2019-04-16 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101812817 |
| 230001697 | 230011317 | 1.5 | 52 | Palliative (P) | 2018-10-23 | 2018-11-06 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100546781 |
| 230001706 | 230011318 | 1.59 | 93 | Palliative (P) | null | 2018-01-22 | Bevacizumab 7.5mg/kg | 02 | N | FLUOROURACIL + OXALIPLATIN | 100983724 |
| 230001712 | 230011319 | 1.58 | 55 | null | null | 2021-11-23 | Olaparib | 02 | null | OLAPARIB | 100945253 |
| 230001742 | 230011322 | null | null | Palliative (P) | 2017-03-31 | 2017-03-31 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100341122 |
| 230001768 | 230011323 | 1.56 | 55 | null | 2021-12-05 | 2021-12-18 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101335236 |
| 230001774 | 230011325 | 1.56 | 68.5 | null | 2021-04-22 | 2021-04-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101164593 |
| 230001780 | 230011326 | null | null | Palliative (P) | null | 2021-12-16 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 101475987 |
| 230001810 | 230011329 | 1.76 | 97.6 | null | 2018-07-29 | 2018-08-05 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101108378 |
| 230001812 | 230011330 | 1.57 | 60.9 | Palliative (P) | null | 2021-06-02 | PEMBROLIZUMAB | 02 | N | CISPLATIN + GEMCITABINE | 101686049 |
| 230001817 | 230011332 | 1.64 | 47 | Palliative (P) | null | 2021-12-26 | Olaparib | 02 | N | OLAPARIB | 100834006 |
| 230001819 | 230011333 | null | null | Neo-adjuvant (N) | 2022-04-11 | 2022-04-14 | null | 02 | N | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 101032091 |
| 230001835 | 230011334 | 1.61 | 53.4 | Palliative (P) | 2021-11-23 | 2021-11-24 | Rucaparib | 02 | N | RUCAPARIB | 101058651 |
| 230001880 | 230011338 | 1.59 | 66.9 | null | null | 2021-10-17 | null | null | null | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 101351228 |
| 230001886 | 230011339 | 1.61 | 101 | null | 2018-09-09 | 2018-09-09 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 100798503 |
| 230001925 | 230011342 | 1.55 | 62.5 | null | null | 2022-05-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100276572 |
| 230001941 | 230011346 | 1.61 | 82.3 | Palliative (P) | 2021-04-11 | 2021-07-08 | null | null | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100644877 |
| 230001942 | 230011347 | 1.51 | 63.2 | null | 2022-05-25 | 2022-05-25 | Niraparib | 02 | null | NIRAPARIB | 100920468 |
| 230001955 | 230011349 | 1.67 | 68.6 | Adjuvant (A) | 2021-05-10 | 2021-05-10 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100203421 |
| 230001959 | 230011350 | 1.64 | 85 | null | 2021-11-04 | 2021-12-11 | Olaparib | 02 | null | OLAPARIB | 100633551 |
| 230001971 | 230011351 | 1.67 | 83.5 | Adjuvant (A) | null | 2021-10-17 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101171132 |
| 230001982 | 230011352 | 1.68 | 78.15 | null | null | 2018-08-26 | Cisplatin + Radiotherapy | 02 | null | ICON8B TRIAL | 101163629 |
| 230002050 | 230011355 | 1.5 | 61.4 | null | 2019-09-03 | 2019-11-06 | Rucaparib | 02 | null | RUCAPARIB | 101559296 |
| 230002078 | 230011358 | 1.69 | 65 | Curative (C) | null | 2021-04-11 | null | 02 | null | AZACITIDINE | 101221344 |
| 230002089 | 230011359 | 1.67 | 68.6 | null | 2021-06-09 | 2021-06-22 | Bevacizumab | 02 | null | BEVACIZUMAB | 101402009 |
| 230002096 | 230011360 | null | null | null | 2021-05-30 | 2021-09-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100069176 |
| 230002117 | 230011363 | 1.72 | 72 | Adjuvant (A) | 2021-10-25 | 2021-12-27 | CARBOPLATIN | 02 | Y | CARBOPLATIN | 100477391 |
| 230002124 | 230011365 | 1.59 | 64.5 | null | 2020-09-06 | 2020-09-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100318201 |
| 230002148 | 230011369 | 1.65 | 115.4 | null | 2022-03-28 | 2022-04-27 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101606687 |
| 230002179 | 230011371 | 1.58 | 53.6 | Palliative (P) | null | 2021-12-18 | Carboplatin + Topotecan | 02 | null | CISPLATIN | 100556662 |
| 230002219 | 230011373 | null | null | null | null | 2021-12-27 | null | null | null | CARBOPLATIN + GEMCITABINE | 100788570 |
| 230002234 | 230011375 | 1.7 | 75 | null | 2021-11-06 | 2022-05-17 | PACLITAXEL | 02 | null | PACLITAXEL | 101273499 |
| 230002257 | 230011377 | 1.59 | 66.6 | Palliative (P) | 2022-01-05 | 2022-04-30 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100731899 |
| 230002258 | 230011378 | null | null | Palliative (P) | 2022-03-26 | 2022-04-02 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | TRIAL UNSPECIFIED | 100778972 |
| 230002349 | 230011384 | null | null | null | 2021-07-24 | 2021-07-28 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100379957 |
| 230002354 | 230011385 | 1.64 | 66 | null | 2021-07-18 | 2021-10-27 | null | 02 | null | NIVOLUMAB | 101815667 |
| 230002390 | 230011386 | 1.52 | 48.4 | null | 2021-05-13 | 2021-05-24 | VAI (Ifos 3g/m2) | N | null | NIVOLUMAB | 100193772 |
| 230002409 | 230011388 | null | null | Palliative (P) | 2021-03-26 | 2021-03-30 | null | 02 | N | TRIAL UNSPECIFIED | 100843848 |
| 230002410 | 230011389 | 1.65 | 93.4 | null | 2022-01-26 | 2022-02-08 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100477175 |
| 230002412 | 230011391 | 1.67 | 93 | null | 2019-11-17 | 2020-04-21 | null | null | null | CYCLOPHOSPHAMIDE | 101528187 |